These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 4980451

  • 41. Extremely high exposures in an obese patient receiving high-dose cyclophosphamide, thiotepa and carboplatin.
    De Jonge ME, Mathôt RA, Van Dam SM, Beijnen JH, Rodenhuis S.
    Cancer Chemother Pharmacol; 2002 Sep; 50(3):251-5. PubMed ID: 12203108
    [Abstract] [Full Text] [Related]

  • 42. High dose mitoxantrone with thiotepa, cyclophosphamide and autologous stem cell rescue for high risk stage II and stage III breast cancer. German GABG-4/EH-93-Study.
    Zander AR, Krüger W, Kröger N, Damon L, Königmann M, Berdel WE, Gieseking F, Schäfer-Eckart K, Möbus V, Frickhofen N, Wandt H, Illiger HJ, Metzner B, Kolbe K, Wörmann B, Trümper L, Huber C, Hossfeld DK, Maass H, Jonat W.
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S24-5. PubMed ID: 8899165
    [No Abstract] [Full Text] [Related]

  • 43. [Comparative evaluation of thiphosphamide, cyclophosphane, methotrexate and 5-fluorouracil in the treatment of breast cancer].
    Sokolova VD, Perevodchikova NI.
    Vestn Akad Med Nauk SSSR; 1971 Sep; 26(3):59-65. PubMed ID: 4996463
    [No Abstract] [Full Text] [Related]

  • 44. [Drug therapy combination in the management of advanced breast cancer].
    Isola LM, Palau M, Cremeruis de Sica S, Pereyra MA, Alzugaray AE.
    Prensa Med Argent; 1970 Jul 31; 57(22):1088-93. PubMed ID: 5476537
    [No Abstract] [Full Text] [Related]

  • 45. [CMF or CAF combination chemotherapy for breast cancer].
    Ota J.
    Gan To Kagaku Ryoho; 1996 Dec 31; 23(14):1886-90. PubMed ID: 8978791
    [Abstract] [Full Text] [Related]

  • 46. [Multicentric prospective, randomized study of the role of filgrastim (G-CSF) after transplant of hematopoietic progenitor cells mobilized with G-CSF in patients with cancer of the breast].
    Hornedo J, Sola C, Solano C, Lluch A, Benavides M, López López J, García Conde J, Cortés-Funes H.
    Sangre (Barc); 1997 Apr 31; 42 Suppl 1():54-6. PubMed ID: 9381305
    [No Abstract] [Full Text] [Related]

  • 47. Lessons from the initial adjuvant cyclophosphamide, methotrexate, and fluorouracil studies in operable breast cancer.
    Bonadonna G, Valagussa P, Veronesi U.
    J Clin Oncol; 2008 Jan 20; 26(3):342-4. PubMed ID: 18202404
    [No Abstract] [Full Text] [Related]

  • 48. [Palliative treatment of ovarian cancers with the association of thiotepa and of 5-fluoro-uracil].
    Simon G, Brunet R, Chauvergne J.
    Bord Med; 1971 May 20; 4(5):1523-30. PubMed ID: 4105607
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. A case of manic episode during treatment with 5-fluorouracil, epirubicin and cyclophosphamide for breast cancer.
    Pacchiarotti I, Mazzarini L, Pellegrini P, Venturelli V, Sani G, Sánchez-Moreno J, Mancinelli I, Tatarelli R, Kotzalidis GD, Girardi P.
    Gen Hosp Psychiatry; 2007 May 20; 29(5):461-3. PubMed ID: 17888816
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. IV. COMBINATION OF CHEMOTHERAPY AND SURGERY IN THE TREATMENT OF CANCER. INTRA-ARTERIAL CANCER CHEMOTHERAPY WITH OR WITHOUT AN ISOLATED EXTRACORPOREAL CIRCUIT.
    GENTIL F.
    Acta Unio Int Contra Cancrum; 1964 May 20; 20():57-62. PubMed ID: 14151984
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Aprepitant inhibits cyclophosphamide bioactivation and thiotepa metabolism.
    de Jonge ME, Huitema AD, Holtkamp MJ, van Dam SM, Beijnen JH, Rodenhuis S.
    Cancer Chemother Pharmacol; 2005 Oct 20; 56(4):370-8. PubMed ID: 15838656
    [Abstract] [Full Text] [Related]

  • 57. Pharmacokinetics of cyclophosphamide and thiotepa in a conventional fractionated high-dose regimen compared with a novel simplified unfractionated regimen.
    Ekhart C, Rodenhuis S, Beijnen JH, Huitema AD.
    Ther Drug Monit; 2009 Feb 20; 31(1):95-103. PubMed ID: 19155964
    [Abstract] [Full Text] [Related]

  • 58. Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer.
    Pierga JY, Mouret E, Diéras V, Laurence V, Beuzeboc P, Dorval T, Palangié T, Jouve M, Vincent-Salomon A, Scholl S, Extra JM, Asselain B, Pouillart P.
    Br J Cancer; 2000 Dec 20; 83(11):1480-7. PubMed ID: 11076657
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Intra tumoural chemotherapy in solid malignant human tumours.
    Shanta V.
    Indian J Cancer; 1965 Mar 20; 2(1):64-7. PubMed ID: 4953382
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.